Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients

Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients

Background: We aimed to explore the role of mitochondrial aldehyde dehydrogenase 2 (ALDH2) in prostate cancer (PCa) patients and provide insights into the tumor immune microenvironment (TME) for those patients undergoing radical radiotherapy. Methods: We performed all analyses using R version 3.6.3...

Full description

Bibliographic Details
Main Authors: Dechao Feng, Weizhen Zhu, Jia You, Xu Shi, Ping Han, Wuran Wei, Qiang Wei, Lu Yang
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Molecules
Subjects:
mitochondrial aldehyde dehydrogenase 2
prostate cancer
biochemical recurrence
tumor immune microenvironment
competing endogenous RNA network
Online Access:https://www.mdpi.com/1420-3049/27/18/6000

Similar Items

Similar Items